000 01229 a2200337 4500
005 20250515001518.0
264 0 _c20070917
008 200709s 0 0 eng d
022 _a1543-0790
040 _aNLM
_beng
_cNLM
100 1 _aBharadwaj, Jayaram S
245 0 0 _aReversible diplopia induced by high-dose intravenous IL-2 therapy.
_h[electronic resource]
260 _bClinical advances in hematology & oncology : H&O
_cJul 2004
300 _a471; discussion 472 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aBlepharoptosis
_xchemically induced
650 0 4 _aBrain Edema
_xchemically induced
650 0 4 _aDiplopia
_xchemically induced
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xadministration & dosage
650 0 4 _aInjections, Intravenous
650 0 4 _aInterleukin-2
_xadministration & dosage
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMeninges
_xdrug effects
700 1 _aBlumenthal, Deborah T
700 1 _aSamlowski, Wolfram E
773 0 _tClinical advances in hematology & oncology : H&O
_gvol. 2
_gno. 7
_gp. 471; discussion 472
999 _c15796445
_d15796445